Showing results (501-510 of 573) with videos related to

Sort By:
Pageof 58
Haematologica|December 1, 2020
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndromeAlana Vicente, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, et al.
Leukemia & Lymphoma|December 23, 2015
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imagingManisha Bhutani, Baris Turkbey, Esther Tan, et al.
Leukemia Research|December 23, 2018
MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestationsLisa J McReynolds, Yanqin Yang, Hong Yuen Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II StudyCarsten U Niemann, Sarah E M Herman, Irina Maric, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
Novel Majeed Syndrome-Causing LPIN2 Mutations Link Bone Inflammation to Inflammatory M2 Macrophages and Accelerated OsteoclastogenesisFarzana Bhuyan, Adriana A de Jesus, Jacob Mitchell, et al.
Blood Advances|August 24, 2021
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Ifeyinwa Emmanuela Obiorah, Bhavisha A Patel, Emma M Groarke, et al.
Annals of the Academy of Medicine, Singapore|September 25, 2004
Clinico-pathological conference 2002E W Odell, M Aldred, R Carlos, et al.
Oral Diseases|June 24, 2017
Clinical and genetic analysis of patients with cherubismR A Machado, Har Pontes, F R Pires, et al.
Molecular Cancer Therapeutics|January 25, 2006
Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivoHolly K Koblish, Shuyuan Zhao, Carol F Franks, et al.
Blood|February 18, 2017
Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cellsHeinrich Schlums, Moonjung Jung, Hongya Han, et al.
Pageof 58